Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Yan Hwang

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Cancer|May 16, 2019
Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective studyHarinder Gill, Cyrus R Kumana, Rita Yim, et al.
British Journal of Haematology|June 25, 2025
Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemiaWing-Yan Leung, Tracy Yuen-Han Lee, Yu-Yan Hwang, et al.
Cancer Medicine|March 19, 2020
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantationHarinder Gill, Rita Yim, Herbert H Pang, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Cancer|May 16, 2019
Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective studyHarinder Gill, Cyrus R Kumana, Rita Yim, et al.
British Journal of Haematology|June 25, 2025
Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemiaWing-Yan Leung, Tracy Yuen-Han Lee, Yu-Yan Hwang, et al.
Cancer Medicine|March 19, 2020
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantationHarinder Gill, Rita Yim, Herbert H Pang, et al.
Pageof 6